The influence of treatment on quality of life in systemic lupus erythematosus patients.
OBJECTIVE
Systemic lupus erythematosus is an autoimmune disease with uncertain prognosis as to the course. The patients need pharmacotherapy all their life. The main aim of this study was to determinate the impact of therapeutic schedules on patients' quality of life.


METHODS
The study was performed on 83 patients who were divided into five groups according to methods of treatment used. Quality of life was measured using MOS SF-36.


RESULTS
Obtained results revealed that therapeutic schedules have the highest influence on patients' social functioning. The more medicaments the patients use, the lower their quality of life.


CONCLUSIONS
The type of medicaments and therapeutic schemes adopted affect the patients' quality of life. Nevertheless, quality of life and the patients' attitude to it are very subjective and are also influenced by the clinical state of the patients as well as many other factors such as socioeconomic and demographic.
Kulczycka
L
L
Medical University of Lodz - Department of Dermatology and Venereology, Krzemieniecka Street no. 5 Lodz 94-017, Poland.
Sysa-Jedrzejowska
A
A
Robak
E
E
D000328:Adult; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D011788:Quality of Life; D011795:Surveys and Questionnaires
D005938:Glucocorticoids